Shandong Realcan Pharmaceutical Co Ltd (002589) — Long-term Investment Intensity

Latest as of September 2019: 1.3%

Shandong Realcan Pharmaceutical Co Ltd (002589) has a Long-term Investment Intensity of 1.3% as of September 2019. Long-term investments of CN¥467.86 Million represent 1.3% of total assets of CN¥37.23 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check 002589 asset resilience ratio to evaluate the company's liquid asset resilience ratio.

LT Investment Intensity

1.3%
LT Investments / Total Assets

Long-term Investments

CN¥467.86 Million
CNY

Total Assets

CN¥37.23 Billion
CNY

Country

China
SHE

Shandong Realcan Pharmaceutical Co Ltd Long-term Investment Intensity (2015–2018)

This chart shows how Shandong Realcan Pharmaceutical Co Ltd's Long-term Investment Intensity has evolved across 4 annual periods from 2015 to 2018. As of September 2019, the intensity stands at 1.3%, reflecting long-term investments of CN¥467.86 Million against total assets of CN¥37.23 Billion CNY. For the complete balance sheet picture, see Shandong Realcan Pharmaceutical Co Ltd balance sheet assets.

Annual Long-term Investment Intensity for Shandong Realcan Pharmaceutical Co Ltd (2015–2018)

The table below presents the year-by-year Long-term Investment Intensity for Shandong Realcan Pharmaceutical Co Ltd from 2015 to 2018, covering 4 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. Read Shandong Realcan Pharmaceutical Co Ltd (002589) financial obligations for a breakdown of total debt and financial obligations.

Year LT Investment Intensity LT Investments (CNY) Total Assets Change (pp)
2018 0.8% CN¥268.63 Million CN¥34.84 Billion ▲ +0.4 pp
2017 0.4% CN¥94.60 Million CN¥26.98 Billion ▲ +0.3 pp
2016 0.1% CN¥9.90 Million CN¥15.66 Billion ▼ 0.0 pp
2015 0.1% CN¥6.68 Million CN¥8.86 Billion
pp = percentage points